Novel 3D-printed Electrodes for Implantable Biopotential Monitoring.

A major bottleneck in the manufacturing process of a medical implant capable of biopotential measurements is the design and assembly of a conductive electrode interface. This paper presents the use of a novel 3D-printing process to integrate conductive metal surfaces on a low-temperature co-fired ceramic base to be deployed as electrodes for electrocardiography (ECG) implants for small animals. In order to fit the ECG sensing system within the size of an injectable microchip implant, the electronics along with a pin-type lithium-ion battery are inserted into a cylindrical glass tube with both ends sealed by these 3D printed composite electrode discs using biomedical epoxy. In the scope of this paper, we present a proof-of-concept in vivo experiment for recording ECG from an avian animal model under local anesthesia to verify the electrode performance. Simultaneous recording with a commercial device validated the measurements, demonstrating promising accuracy in heart rate and breathing rate monitoring. This novel technology could open avenues for the mass manufacturing of miniaturized ECG implants.Clinical relevance- A novel manufacturing process and an implantable system are presented for continuous physiological monitoring of animals to be used by veterinarians, animal scientists, and biomedical researchers with potential future applications in human health monitoring.

Ketogenic Diet Therapy for Intractable Epilepsy in Infantile Alexander Disease: A Small Case Series and Analyses of Astroglial Chemokines and Proinflammatory Cytokines.

In infantile Alexander disease (iAxD), one of the serious symptoms is intractable epilepsy, and some reports have suggested that neuroinflammation may be involved in the pathophysiology of the disease. Drug-resistant seizures adversely affect not only the quality of life of the caregivers and patients, but also patients' lifespan. Thus, controlling epilepsy is clinically important. For intractable childhood epilepsy, ketogenic diet therapy (KDT) is well-established, but its effects on iAxD have not been characterized. Here, we describe the use of KDT in three iAxD patients experiencing drug-resistant seizures. In all three cases, the formerly intractable epilepsies were well controlled by KDT. However, the brain magnetic resonance imaging findings deteriorated even after the epilepsy was controlled. In addition, the concentrations of monocyte chemotactic protein-1 and proinflammatory cytokines in the cerebrospinal fluid of the patients remained still high. KDT is effective in controlling epilepsy in iAxD. Our results clinically support previous reports arguing the involvement of neuroinflammation in the pathophysiology of iAxD.　Although KDT cannot prevent disease progression, earlier initiation might contribute to a better prognosis.